Paroxetine vs Pembrolizumab
Paroxetine vs Pembrolizumab: Overview
This comparison examines the pharmacological differences between Paroxetine and Pembrolizumab.
Mechanism of Action
Paroxetine: Potent selective serotonin reuptake inhibitor with additional muscarinic and NE reuptake inhibition.
Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.
Pharmacokinetics
Half-life: Paroxetine — 21 hours; Pembrolizumab — 26 days.
Chemical Properties
Molecular Formula: Paroxetine — C19H20FNO3.
Molecular Weight: Paroxetine — 329.3730 g/mol.
Type: Paroxetine — Small molecule; Pembrolizumab — Antibody.